vs
First Internet Bancorp(INBK)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
First Internet Bancorp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍($43.1M vs $35.5M),First Internet Bancorp净利率更高(5.8% vs -304.2%,领先310.1%),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs 15.4%)
第一互联网班克公司是一家美国银行控股公司,总部位于印第安纳州费舍尔斯,旗下唯一子公司为印第安纳第一互联网银行。该银行是美国最早一批仅通过线上与电话开展业务、不设实体网点的州特许银行之一。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
INBK vs RXRX — 直观对比
营收规模更大
INBK
是对方的1.2倍
$35.5M
净利率更高
INBK
高出310.1%
-304.2%
两年增速更快
RXRX
近两年复合增速
15.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $43.1M | $35.5M |
| 净利润 | $2.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 5.8% | -304.2% |
| 营收同比 | — | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益(稀释后) | $0.29 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
INBK
RXRX
| Q1 26 | $43.1M | — | ||
| Q4 25 | $30.3M | $35.5M | ||
| Q3 25 | $5.7M | $5.2M | ||
| Q2 25 | $33.5M | $19.2M | ||
| Q1 25 | $35.5M | $14.7M | ||
| Q4 24 | $39.5M | $4.5M | ||
| Q3 24 | $33.8M | $26.1M | ||
| Q2 24 | $32.4M | $14.4M |
净利润
INBK
RXRX
| Q1 26 | $2.5M | — | ||
| Q4 25 | $5.3M | $-108.1M | ||
| Q3 25 | $-41.6M | $-162.3M | ||
| Q2 25 | $193.0K | $-171.9M | ||
| Q1 25 | $943.0K | $-202.5M | ||
| Q4 24 | $7.3M | $-178.9M | ||
| Q3 24 | $7.0M | $-95.8M | ||
| Q2 24 | $5.8M | $-97.5M |
毛利率
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | 18.1% | -304.8% | ||
| Q3 25 | -956.1% | -3327.6% | ||
| Q2 25 | -5.5% | -916.8% | ||
| Q1 25 | 0.1% | -1297.9% | ||
| Q4 24 | 21.1% | -4042.4% | ||
| Q3 24 | 22.5% | -377.1% | ||
| Q2 24 | 18.5% | -697.4% |
净利率
INBK
RXRX
| Q1 26 | 5.8% | — | ||
| Q4 25 | 17.4% | -304.2% | ||
| Q3 25 | -729.1% | -3135.3% | ||
| Q2 25 | 0.6% | -894.2% | ||
| Q1 25 | 2.7% | -1373.3% | ||
| Q4 24 | 18.6% | -3935.5% | ||
| Q3 24 | 20.7% | -367.5% | ||
| Q2 24 | 17.8% | -676.6% |
每股收益(稀释后)
INBK
RXRX
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.60 | $-0.17 | ||
| Q3 25 | $-4.76 | $-0.36 | ||
| Q2 25 | $0.02 | $-0.41 | ||
| Q1 25 | $0.11 | $-0.50 | ||
| Q4 24 | $0.82 | $-0.56 | ||
| Q3 24 | $0.80 | $-0.34 | ||
| Q2 24 | $0.67 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $374.3M | $1.1B |
| 总资产 | $5.6B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | $456.8M | $743.3M | ||
| Q3 25 | $787.7M | $659.8M | ||
| Q2 25 | $446.4M | $525.1M | ||
| Q1 25 | $394.5M | $500.5M | ||
| Q4 24 | $466.4M | $594.4M | ||
| Q3 24 | $712.5M | $427.6M | ||
| Q2 24 | $396.8M | $474.3M |
总债务
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | $249.5M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $295.0M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M |
股东权益
INBK
RXRX
| Q1 26 | $374.3M | — | ||
| Q4 25 | $359.8M | $1.1B | ||
| Q3 25 | $352.2M | $1.0B | ||
| Q2 25 | $390.2M | $919.1M | ||
| Q1 25 | $387.7M | $933.9M | ||
| Q4 24 | $384.1M | $1.0B | ||
| Q3 24 | $385.1M | $524.6M | ||
| Q2 24 | $372.0M | $584.4M |
总资产
INBK
RXRX
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.6B | $1.5B | ||
| Q3 25 | $5.6B | $1.4B | ||
| Q2 25 | $6.1B | $1.3B | ||
| Q1 25 | $5.9B | $1.3B | ||
| Q4 24 | $5.7B | $1.4B | ||
| Q3 24 | $5.8B | $726.5M | ||
| Q2 24 | $5.3B | $775.9M |
负债/权益比
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.77× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $-46.1M | ||
| Q3 25 | $37.1M | $-117.4M | ||
| Q2 25 | $-90.2M | $-76.4M | ||
| Q1 25 | $32.8M | $-132.0M | ||
| Q4 24 | $13.0M | $-115.4M | ||
| Q3 24 | $331.0K | $-59.2M | ||
| Q2 24 | $16.0M | $-82.2M |
自由现金流
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | $2.2M | $-47.3M | ||
| Q3 25 | $37.0M | $-117.6M | ||
| Q2 25 | $-90.8M | $-79.6M | ||
| Q1 25 | $32.6M | $-133.8M | ||
| Q4 24 | $10.4M | $-116.7M | ||
| Q3 24 | $-270.0K | $-63.8M | ||
| Q2 24 | $15.5M | $-83.4M |
自由现金流率
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | 7.3% | -133.1% | ||
| Q3 25 | 648.0% | -2272.5% | ||
| Q2 25 | -270.7% | -413.9% | ||
| Q1 25 | 91.9% | -907.4% | ||
| Q4 24 | 26.3% | -2567.7% | ||
| Q3 24 | -0.8% | -244.6% | ||
| Q2 24 | 47.8% | -578.5% |
资本支出强度
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | 3.5% | ||
| Q3 25 | 1.9% | 4.7% | ||
| Q2 25 | 1.9% | 16.4% | ||
| Q1 25 | 0.5% | 12.4% | ||
| Q4 24 | 6.6% | 28.6% | ||
| Q3 24 | 1.8% | 17.5% | ||
| Q2 24 | 1.7% | 8.2% |
现金转化率
INBK
RXRX
| Q1 26 | — | — | ||
| Q4 25 | 0.65× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -467.21× | — | ||
| Q1 25 | 34.81× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 2.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INBK
| Net Interest Income | $31.6M | 73% |
| Noninterest Income | $11.5M | 27% |
RXRX
暂无分部数据